Advanced Medical Solutions Group plc (AIM: AMS)
London
· Delayed Price · Currency is GBP · Price in GBX229.50
-1.50 (-0.65%)
Sep 11, 2024, 4:35 PM GMT+1
AMS Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 126.21 | 126.21 | 124.33 | 108.6 | 86.8 | 102.37 | Upgrade
|
| Revenue Growth (YoY) | 1.51% | 1.51% | 14.48% | 25.12% | -15.21% | -0.22% | Upgrade
|
| Cost of Revenue | 56.07 | 56.07 | 50.91 | 47.53 | 40.76 | 41.89 | Upgrade
|
| Gross Profit | 70.14 | 70.14 | 73.42 | 61.07 | 46.04 | 60.48 | Upgrade
|
| Selling, General & Admin | 52.19 | 52.19 | 49 | 38.45 | 34.73 | 35.56 | Upgrade
|
| Other Operating Expenses | -0.93 | -0.93 | -0.48 | -0.38 | -0.25 | -0.38 | Upgrade
|
| Operating Expenses | 51.26 | 51.26 | 48.53 | 38.07 | 34.48 | 35.19 | Upgrade
|
| Operating Income | 18.88 | 18.88 | 24.89 | 23 | 11.56 | 25.3 | Upgrade
|
| Interest Expense | -0.38 | -0.38 | -0.64 | -0.67 | -0.69 | -0.74 | Upgrade
|
| Interest & Investment Income | 2.47 | 2.47 | 0.82 | 0.08 | 0.22 | 0.41 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.19 | 0.19 | 0.84 | -0.43 | -0.17 | 0.35 | Upgrade
|
| EBT Excluding Unusual Items | 21.16 | 21.16 | 25.91 | 21.98 | 10.92 | 25.31 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.83 | -1.05 | Upgrade
|
| Pretax Income | 21.16 | 21.16 | 25.91 | 21.98 | 10.09 | 24.26 | Upgrade
|
| Income Tax Expense | 5.27 | 5.27 | 5.5 | 4.5 | 1.51 | 5.34 | Upgrade
|
| Net Income | 15.89 | 15.89 | 20.41 | 17.48 | 8.58 | 18.92 | Upgrade
|
| Net Income to Common | 15.89 | 15.89 | 20.41 | 17.48 | 8.58 | 18.92 | Upgrade
|
| Net Income Growth | -22.14% | -22.14% | 16.73% | 103.65% | -54.63% | -15.87% | Upgrade
|
| Shares Outstanding (Basic) | 216 | 216 | 217 | 216 | 215 | 215 | Upgrade
|
| Shares Outstanding (Diluted) | 219 | 219 | 219 | 218 | 218 | 217 | Upgrade
|
| Shares Change (YoY) | -0.09% | -0.09% | 0.54% | 0.22% | 0.46% | 0.36% | Upgrade
|
| EPS (Basic) | 0.07 | 0.07 | 0.09 | 0.08 | 0.04 | 0.09 | Upgrade
|
| EPS (Diluted) | 0.07 | 0.07 | 0.09 | 0.08 | 0.04 | 0.09 | Upgrade
|
| EPS Growth | -22.04% | -22.04% | 16.11% | 103.30% | -54.82% | -16.24% | Upgrade
|
| Free Cash Flow | 8.8 | 8.8 | 23.14 | 29.26 | 19.17 | 19.03 | Upgrade
|
| Free Cash Flow Per Share | 0.04 | 0.04 | 0.11 | 0.13 | 0.09 | 0.09 | Upgrade
|
| Dividend Per Share | 0.024 | 0.024 | 0.021 | 0.019 | 0.017 | 0.015 | Upgrade
|
| Dividend Growth | 9.77% | 9.77% | 10.26% | 14.71% | 9.68% | 17.42% | Upgrade
|
| Gross Margin | 55.57% | 55.57% | 59.05% | 56.23% | 53.04% | 59.08% | Upgrade
|
| Operating Margin | 14.96% | 14.96% | 20.02% | 21.18% | 13.32% | 24.71% | Upgrade
|
| Profit Margin | 12.59% | 12.59% | 16.41% | 16.10% | 9.89% | 18.48% | Upgrade
|
| Free Cash Flow Margin | 6.97% | 6.97% | 18.61% | 26.94% | 22.08% | 18.59% | Upgrade
|
| EBITDA | 26.6 | 26.6 | 30.94 | 28.67 | 16.03 | 29.07 | Upgrade
|
| EBITDA Margin | 21.07% | 21.07% | 24.89% | 26.40% | 18.47% | 28.39% | Upgrade
|
| D&A For EBITDA | 7.71 | 7.71 | 6.05 | 5.67 | 4.47 | 3.77 | Upgrade
|
| EBIT | 18.88 | 18.88 | 24.89 | 23 | 11.56 | 25.3 | Upgrade
|
| EBIT Margin | 14.96% | 14.96% | 20.02% | 21.18% | 13.32% | 24.71% | Upgrade
|
| Effective Tax Rate | 24.90% | 24.90% | 21.24% | 20.48% | 14.92% | 22.01% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.